Rate < Rats < Rats de lignée LEW

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Rats

Number of relevant bibliographic references: 18.

Ident.	Authors (with country if any)	Title
001094 (2018)	Indu Javeri [États-Unis] ; Kaliappanadar Nellaiappan [États-Unis] ; Charles Mcnemar [États-Unis] ; Kirill Yakovlevsky [États-Unis] ; Amina Soukrati [États-Unis] ; Phanindra Velisetty [États-Unis] ; Bijay Misra [États-Unis]	Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.
001422 (2018)	Mahdi Abusalameh [Royaume-Uni] ; Preeti Mahankali-Rao [Royaume-Uni] ; Susie Earl [Royaume-Uni]	Discitis caused by rat bite fever in a rheumatoid arthritis patient on tocilizumab-first ever case.
001443 (2018)	Amany El-Shahawy Abdel-Maged [Égypte] ; Amany M. Gad [Égypte] ; Amal Kamal Abdel-Aziz [Égypte] ; Mohammad M. Aboulwafa [Égypte] ; Samar S. Azab [Égypte]	Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis.
001781 (2017)	Yuangui Lin [République populaire de Chine] ; Lian Liu [République populaire de Chine] ; Haixia Jiang [République populaire de Chine] ; Jieshu Zhou [République populaire de Chine] ; Yuying Tang [République populaire de Chine]	Inhibition of interleukin-6 function attenuates the central sensitization and pain behavior induced by osteoarthritis.
001822 (2017)	Yusuf Hançerli [Turquie] ; Mustafa Kaplan ; Alpaslan Tano Lu ; Soner Ye Ilba ; Zafer Küçükodac ; Muhammet Y Ld R M ; Gizem Narl ; Yusuf Serdar Sakin	Efficacy of tocilizumab treatment in cerulein-induced experimental acute pancreatitis model in rats.
001982 (2016)	H Kübra Elcio Lu [Turquie] ; Ersin Aslan [Turquie] ; Sarfraz Ahmad [États-Unis] ; Saadet Alan [Turquie] ; Emine Salva [Turquie] ; Ö Haluk Elcioglu [Turquie] ; Levent Kabasakal [Turquie]	Tocilizumab's effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer's model.
001985 (2016)	Shaojun Wang [République populaire de Chine] ; Jun Zhou ; Weijie Kang ; Zhaoni Dong ; Hezuo Wang	Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model.
001B84 (2016)	Larry Lam [États-Unis] ; Lydia Chin ; Ramesh C. Halder ; Bien Sagong ; Sam Famenini ; James Sayre [États-Unis] ; Dennis Montoya [États-Unis] ; Liudmilla Rubbi [États-Unis] ; Matteo Pellegrini [États-Unis] ; Milan Fiala [États-Unis]	Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients.
001B94 (2016)	Ke-Ling Chen [République populaire de Chine] ; Zhao-Ying Lv ; Hong-Wei Yang ; Yong Liu ; Fei-Wu Long ; Bin Zhou ; Xiao-Feng Sun ; Zhi-Hai Peng ; Zong-Guang Zhou ; Yuan Li	Effects of Tocilizumab on Experimental Severe Acute Pancreatitis and Associated Acute Lung Injury.
001C11 (2016)	Jian Qi [République populaire de Chine] ; Chen Chen [République populaire de Chine] ; Qing-Xi Meng [République populaire de Chine] ; Yan Wu [République populaire de Chine] ; Haitao Wu [République populaire de Chine] ; Ting-Bao Zhao [République populaire de Chine]	Crosstalk between Activated Microglia and Neurons in the Spinal Dorsal Horn Contributes to Stress-induced Hyperalgesia.
001C90 (2016)	Mine Islimye Taskin [Turquie] ; Aysenur Cakir Gungor [Turquie] ; Ertan Adali [Turquie] ; Arzu Yay [Turquie] ; Gozde Ozge Onder [Turquie] ; Umit Inceboz [Turquie]	A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model.
001F31 (2015)	Mine Islimye Taskin [Turquie] ; Onur Topcu [Turquie] ; Arzu Yay [Turquie] ; Gulten Erken ; Esra Balcio Lu [Turquie] ; Ertan Adali [Turquie] ; Adnan Adil Hismiogullar [Turquie]	Prevention of ovarian hyperstimulation syndrome in a rat model: comparison of the efficacy of tocilizumab with that of ranibizumab, cabergoline, and a gonadotropin-releasing hormone antagonist.
001F36 (2015)	Chun Yang [Japon] ; Yukihiko Shirayama [Japon] ; Ji-Chun Zhang [Japon] ; Qian Ren [Japon] ; Kenji Hashimoto [Japon]	Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress.
001F86 (2015)	Renpeng Zhou [République populaire de Chine] ; Xiaoshan Wu [République populaire de Chine] ; Zhisen Wang [République populaire de Chine] ; Jinfang Ge [République populaire de Chine] ; Feihu Chen [République populaire de Chine]	Interleukin-6 enhances acid-induced apoptosis via upregulating acid-sensing ion channel 1a expression and function in rat articular chondrocytes.
001F93 (2015)	Esin Sogutlu Sari [Turquie] ; Alper Yazici ; Hasan Aksit ; Arzu Yay ; Gözde Sahin ; Onur Yildiz ; Sitki Samet Ermis ; Kamil Seyrek ; Betul Yalcin	Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
002487 (2014)	Shashi Gupta [États-Unis] ; Masao Hirota ; Sheela M. Waugh ; Ikuo Murakami ; Tomoki Suzuki ; Masahiro Muraguchi ; Masafumi Shibamori ; Yuichi Ishikawa ; Thale C. Jarvis ; Jeffrey D. Carter ; Chi Zhang ; Bharat Gawande ; Michael Vrkljan ; Nebojsa Janjic ; Daniel J. Schneider	Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor.
002755 (2013)	Jutatip Guptarak [États-Unis] ; Sheshali Wanchoo ; Julieann Durham-Lee ; Yewen Wu ; Dragoslava Zivadinovic ; Adriana Paulucci-Holthauzen ; Olivera Nesic	Inhibition of IL-6 signaling: A novel therapeutic approach to treating spinal cord injury pain.
003C34 (2010)	Jordan S. Fridman [États-Unis] ; Peggy A. Scherle ; Robert Collins ; Timothy C. Burn ; Yanlong Li ; Jun Li ; Maryanne B. Covington ; Beth Thomas ; Paul Collier ; Margaret F. Favata ; Xiaoming Wen ; Jack Shi ; Ryan Mcgee ; Patrick J. Haley ; Stacey Shepard ; James D. Rodgers ; Swamy Yeleswaram ; Greg Hollis ; Robert C. Newton ; Brian Metcalf ; Steven M. Friedman ; Kris Vaddi	Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Rats" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Rats" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Rats
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021